T1	Intervention 175 340	combination of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and recombinant human erythropoietin (rHuEPO) given after autologous BMT
T2	Intervention 447 465	concurrent control
T3	Intervention 473 528	historical control patients treated with rhGM-CSF alone
